RASA1 Gene Capillary malformation-arteriovenous malformation Genetic Test
At DNA Labs UAE, we offer the RASA1 Gene Capillary malformation-arteriovenous malformation Genetic Test. This test is designed to detect mutations in the RASA1 gene, which is associated with the development of abnormal blood vessels known as arteriovenous malformations (AVMs) in the skin and other organs.
Test Details
The RASA1 gene Capillary malformation-arteriovenous malformation (CM-AVM) is a genetic disorder characterized by the development of abnormal blood vessels, known as arteriovenous malformations (AVMs), in the skin and other organs. CM-AVM is caused by mutations in the RASA1 gene, which provides instructions for making a protein involved in cell signaling and blood vessel development.
To diagnose CM-AVM, a genetic test known as Next-Generation Sequencing (NGS) can be performed. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes, including the RASA1 gene. This test involves sequencing the DNA of an individual to identify any mutations or variations in the RASA1 gene that may be associated with CM-AVM.
NGS genetic testing for CM-AVM can help confirm a diagnosis in individuals with suspected or clinically diagnosed CM-AVM. It can also be used for carrier testing in family members of affected individuals or for prenatal testing in couples with a family history of CM-AVM.
It is important to note that genetic testing should be performed and interpreted by a qualified geneticist or genetic counselor who can provide appropriate genetic counseling and guidance based on the results. The results of genetic testing can help in understanding the underlying cause of CM-AVM, predicting the risk of recurrence in families, and guiding management and treatment options.
Test Components and Price
Test Name: RASA1 Gene Capillary malformation-arteriovenous malformation Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Test Type
Vascular Diseases
Doctor
General Physician
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for RASA1 Gene Capillary malformation-arteriovenous malformation NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RASA1 Gene Capillary malformation-arteriovenous malformation NGS Genetic DNA Test gene RASA1
| Test Name | RASA1 Gene Capillary malformation-arteriovenous malformation Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Vascular Diseases |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for RASA1 Gene Capillary malformation-arteriovenous malformation NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RASA1 Gene Capillary malformation-arteriovenous malformation NGS Genetic DNA Test gene RASA1 |
| Test Details |
RASA1 gene Capillary malformation-arteriovenous malformation (CM-AVM) is a genetic disorder characterized by the development of abnormal blood vessels, known as arteriovenous malformations (AVMs), in the skin and other organs. CM-AVM is caused by mutations in the RASA1 gene, which provides instructions for making a protein involved in cell signaling and blood vessel development. To diagnose CM-AVM, a genetic test known as Next-Generation Sequencing (NGS) can be performed. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes, including the RASA1 gene. This test involves sequencing the DNA of an individual to identify any mutations or variations in the RASA1 gene that may be associated with CM-AVM. NGS genetic testing for CM-AVM can help confirm a diagnosis in individuals with suspected or clinically diagnosed CM-AVM. It can also be used for carrier testing in family members of affected individuals or for prenatal testing in couples with a family history of CM-AVM. It is important to note that genetic testing should be performed and interpreted by a qualified geneticist or genetic counselor who can provide appropriate genetic counseling and guidance based on the results. The results of genetic testing can help in understanding the underlying cause of CM-AVM, predicting the risk of recurrence in families, and guiding management and treatment options. |
